Investigation on the binding behavior of human α1-acid glycoprotein with Janus Kinase inhibitor baricitinib: Multi-spectroscopic and molecular simulation …

SL Jiang, ZY Hu, WJ Wang, L Hu, L Li, SB Kou… - International Journal of …, 2023 - Elsevier
Abstract Baricitinib is a Janus Kinase (JAK) inhibitor that is primarily used to treat moderately
to severely active rheumatoid arthritis in adults and has recently been reported for the …

Molecular interactions of ceftazidime with bovine serum albumin: Spectroscopic, molecular docking, and DFT analyses

MS Ali, J Muthukumaran, HA Al-Lohedan - Journal of Molecular Liquids, 2020 - Elsevier
Ceftazidime is a well-known cephalosporin antibiotic included in the World Health
Organization's list of essential medicines. Herein, we investigated the molecular interactions …

Interaction mechanism of a cysteine protease inhibitor, odanacatib, with human serum albumin: In vitro and bioinformatics studies

NJM Asngari, KA Bakar, SR Feroz, FA Razak… - Biophysical …, 2024 - Elsevier
Odanacatib (ODN) is a selective cathepsin K inhibitor that acts as an anti-resorptive agent to
treat osteoporosis. ODN is also found effective in reducing the effect of severe periodontitis …

Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests

S De Vita, MG Chini, G Saviano, C Finamore, C Festa… - Biomolecules, 2021 - mdpi.com
Natural products have been the main source of bioactive molecules for centuries. We tested
the biological profile of two metabolites extracted from Gentiana lutea L. by means of …

In vitro investigation of the binding characteristics of dacomitinib to human α 1-acid glycoprotein: Multispectral and computational modeling

ZY Hu, HY Sui, QF Zhong, L Hu, JH Shi… - … Acta Part A: Molecular …, 2024 - Elsevier
Dacomitinib is a highly selective second-generation tyrosine kinase inhibitor that can
irreversibly bind to tyrosine kinase and is mainly used in the treatment of lung cancer. The …